publication venue for
- Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation. 2024
- Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients. 2024
- Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis. 2023
- Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation.. 22. 2020
- Cellular therapy injections in today's orthopedic market: A social media analysis.. 19. 2017
- A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.. 18. 2016
- Avoiding pitfalls in bone marrow engraftment analysis: a case study highlighting the weakness of using buccal cells for determining a patient's constitutional genotype after hematopoietic stem cell transplantation.. 15. 2012
- Influence of related donor age on outcomes after peripheral blood stem cell transplantation.. 14. 2012
- Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.. 11. 2009
- Antibody response to GD3 ganglioside is independent of NKT cells.. 10. 2008
- In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring.. 8. 2006
- Can we use monoclonal antibodies to help T cells fight tumors?. 8. 2006
- Persistence makes perfect: the benefits of IL-2 in adoptive immunotherapy.. 7. 2005
- Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells. 2016
- T-cell therapies for HIV: Preclinical successes and current clinical strategies. 2016
- IL-15: targeting CD8+ T cells for immunotherapy. 2005
- Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells. 2015